​

Funding Round

Series A - Axial Biotherapeutics

Series A - Axial Biotherapeutics

Investment Firm

Overview

Axial Therapeutics is a clinical stage biopharmaceutical company harnessing the gut-brain axis to develop novel Central Nervous System.

Announced Date

Dec 01, 2016

Closed on Date

Dec 01, 2016

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Domain Associates

Domain Associates

Domain Associates is a early_stage_venture and late_stage_venture and private_equity firm.

Longwood Fund

Longwood Fund

Longwood Fund is a early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Participant Investors

3

Investor Name
Participant InvestorKairos Ventures
Participant InvestorLongwood Fund
Participant InvestorDomain Associates

Round Details and Background

Axial Biotherapeutics raised $19150000 on 2016-12-01 in Series A

Axial Therapeutics is a clinical stage biopharmaceutical company harnessing the gut-brain axis to develop novel Central Nervous System.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 20, 2019
Series B - Axial Biotherapeutics
1-10.0M
Dec 01, 2016
Series A - Axial Biotherapeutics
3-19.1M
Oct 13, 2021
Series C - Axial Biotherapeutics
8-37.3M
Nov 30, 2016
Series A - Axial Biotherapeutics
4-19.5M

Recent Activity

There is no recent news or activity for this profile.